Painful Price, Potential Promise: Using Analytics to Combat Compound Rx Fraud
The cost of compound pharmaceuticals continues to skyrocket – as much as 18 times what it was just three years ago. Our healthcare system has left the door open for these high price tags and for the unscrupulous to prey on the vulnerable with “miracle cures” or useless dietary supplements. The schemes are endless, with significant risks to patients and their loved ones, even resulting in death.
Learn more about the issue in this webinar:
Presenters: Bill Mahon, president, The MAHON Consulting Group;
and Jean Lyon, RN, MS, vice president of product innovation, HMS